Mutant forms of meningococcal adp-ribosylating toxin

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/31 (2006.01) A61K 39/095 (2006.01) A61K 39/395 (2006.01) C07K 14/22 (2006.01) C07K 16/12 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2497279

NMB1343 is an ADP-ribosylating toxin from Neisseria meningitidis. The invention provides a mutant toxin having a substitution at one or more of amino Glu-109, Glu-111 or Glu-120. The mutations(s) is/are preferably Glu to Asp. The protein of the invention preferably has reduced or eliminated ADP- ribosyltransferase and/or NAD-glycohydrolase activity relative to the wild- type protein.

NMB1343 est une toxine ADP-ribosylante tirée de Neisseria meningitidis. La toxine mutante de l'invention est substituée à une ou à plusieurs positions d'acides aminés, à savoir, Glu-109, Glu-111 ou Glu-120. La ou les mutations concernent de préférence Glu à Asp. La protéine de l'invention possède, de préférence, une activité ADP-ribosyltransférase et/ou NAD-glycohydrolase réduite ou éliminée par rapport à la protéine de type sauvage.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mutant forms of meningococcal adp-ribosylating toxin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mutant forms of meningococcal adp-ribosylating toxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutant forms of meningococcal adp-ribosylating toxin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1632103

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.